United States · FDA National Drug Code directory
Loratadine and Pseudoephedrine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70677-1018_d826c4a9-f53f-4dc4-9f97-08bf29685f3c
- Product NDC
- 70677-1018
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- loratadine and pseudoephedrine
- Labeler
- STRATEGIC SOURCING SERVICES LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230810
- Source listing expiry
- 20261231
Source-listed ingredients
- LORATADINE — 10 mg/1
- PSEUDOEPHEDRINE SULFATE — 240 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BLISTER PACK in 1 CARTON (70677-1018-1) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 70677-1018-1
- 1 BLISTER PACK in 1 CARTON (70677-1018-2) / 15 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 70677-1018-2
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →